Skip to content
Screener

Labcorp Holdings LH Other income, net (Note 6)

Other income, net (Note 6) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$0-100%
Azenta logo
AzentaAZTA
$1.2M+246%
Quest Diagnostics logo
Quest DiagnosticsDGX
$16M+23.1%
NeoGenomics logo
NeoGenomicsNEO
-$17K-104%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$37.41M-24,392%
Exagen Inc. logo
Exagen Inc.XGN
-$132K-184%

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$121.0M-4.0%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$25.67B+18.4%
Enterprise value$32.29B+19.3%
P/E25.6×-2.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Labcorp Holdings’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 6:53 AM EDT
Accession
0000920148-26-000162

FAQ

What is Labcorp Holdings's other income, net (note 6)?
Labcorp Holdings (LH) reported other income, net (note 6) of -$3.5M in Q2 2026.
How has Labcorp Holdings's other income, net (note 6) changed year-over-year?
Labcorp Holdings's other income, net (note 6) increased by 89.3% year-over-year, from -$32.7M to -$3.5M.
What is the long-term trend for Labcorp Holdings's other income, net (note 6)?
Over 2 years (2023 to 2025), Labcorp Holdings's other income, net (note 6) has grown at a 88.4% compound annual growth rate (CAGR), from $15.5M to -$55M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Labcorp Holdings's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude